NO20001400L - Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist - Google Patents

Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist

Info

Publication number
NO20001400L
NO20001400L NO20001400A NO20001400A NO20001400L NO 20001400 L NO20001400 L NO 20001400L NO 20001400 A NO20001400 A NO 20001400A NO 20001400 A NO20001400 A NO 20001400A NO 20001400 L NO20001400 L NO 20001400L
Authority
NO
Norway
Prior art keywords
combination
monoamine oxidase
partial agonist
oxidase inhibitor
alkyl
Prior art date
Application number
NO20001400A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001400D0 (no
Inventor
Stefan Berg
Svante Ross
Seth-Olov Thorberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20001400D0 publication Critical patent/NO20001400D0/no
Publication of NO20001400L publication Critical patent/NO20001400L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20001400A 1997-09-18 2000-03-17 Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist NO20001400L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001602 WO1999013878A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (2)

Publication Number Publication Date
NO20001400D0 NO20001400D0 (no) 2000-03-17
NO20001400L true NO20001400L (no) 2000-05-05

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001400A NO20001400L (no) 1997-09-18 2000-03-17 Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist

Country Status (27)

Country Link
US (1) US6159970A (de)
EP (1) EP1014986B1 (de)
JP (1) JP2001516719A (de)
KR (2) KR20010024087A (de)
CN (1) CN1278727A (de)
AR (1) AR013503A1 (de)
AT (1) ATE270889T1 (de)
AU (1) AU752719B2 (de)
BR (1) BR9812236A (de)
CA (1) CA2302204A1 (de)
DE (1) DE69825062T2 (de)
DK (1) DK1014986T3 (de)
EE (1) EE200000146A (de)
ES (1) ES2222603T3 (de)
HU (1) HUP0100621A2 (de)
ID (1) ID25789A (de)
IL (1) IL134775A0 (de)
IS (1) IS5401A (de)
MX (1) MXPA00002616A (de)
NO (1) NO20001400L (de)
PL (1) PL339368A1 (de)
PT (1) PT1014986E (de)
SE (1) SE9703376D0 (de)
SK (1) SK2832000A3 (de)
TR (1) TR200000725T2 (de)
WO (1) WO1999013878A1 (de)
ZA (1) ZA987804B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (en) * 2001-02-21 2002-08-29 Sankyo Company, Limited Chromene derivatives
US7504395B2 (en) * 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US20090054453A1 (en) * 2006-03-17 2009-02-26 Lilian Alcaraz Novel Tetralins as 5-HT6 Modulators
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
WO2008065141A1 (en) 2006-11-30 2008-06-05 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
ZA200905537B (en) 2007-03-01 2010-10-27 Probiodrug Ag New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
JP6026284B2 (ja) 2010-03-03 2016-11-16 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
EP3461819B1 (de) 2017-09-29 2020-05-27 Probiodrug AG Hemmer der glutaminylcyclase
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204262T1 (de) * 1991-09-18 2001-09-15 Glaxo Group Ltd Benzanilidderivate als 5-ht1d-antagonisten
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Also Published As

Publication number Publication date
SK2832000A3 (en) 2000-09-12
DE69825062D1 (de) 2004-08-19
PT1014986E (pt) 2004-10-29
DE69825062T2 (de) 2005-08-25
SE9703376D0 (sv) 1997-09-18
EP1014986A1 (de) 2000-07-05
AR013503A1 (es) 2000-12-27
JP2001516719A (ja) 2001-10-02
TR200000725T2 (tr) 2000-08-21
ID25789A (id) 2000-11-02
AU9193198A (en) 1999-04-05
IS5401A (is) 2000-03-14
ES2222603T3 (es) 2005-02-01
IL134775A0 (en) 2001-04-30
EP1014986B1 (de) 2004-07-14
CA2302204A1 (en) 1999-03-25
BR9812236A (pt) 2000-07-18
WO1999013878A1 (en) 1999-03-25
CN1278727A (zh) 2001-01-03
AU752719B2 (en) 2002-09-26
KR20010024084A (ko) 2001-03-26
DK1014986T3 (da) 2004-10-25
KR20010024087A (ko) 2001-03-26
HUP0100621A2 (hu) 2001-08-28
ATE270889T1 (de) 2004-07-15
US6159970A (en) 2000-12-12
PL339368A1 (en) 2000-12-18
EE200000146A (et) 2001-02-15
ZA987804B (en) 1999-03-18
NO20001400D0 (no) 2000-03-17
MXPA00002616A (es) 2002-04-24

Similar Documents

Publication Publication Date Title
NO20001400L (no) Kombinasjon av en monoaminooksidaseinhibitor og en h5-HT1B antagonist eller partiell agonist
MY116280A (en) A combination of a 5-ht reuptake inhibitor and a h5-ht 1b antagonist or partial agonist
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
NO20101069L (no) Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva
AR021055A1 (es) Derivados de pirazolopiridina
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
RS50804B (sr) Derivati 2-(1h-indolilsulfanil)-arila za primenu u lečenju afektivnih poremećaja, bola, poremećaja pažnje i hiperaktivnosti (adhd) i stres urinarne inkontinencije
DK0882726T3 (da) Carbazolcarboxamider som 5-HT1F-agonister
NO951980D0 (no) Anvendelse av dimetylbenzofuraner og dimetylbenzopyraner som 5-HT -antagonister
WO1995001170A3 (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
FI943931A (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
FI951631A0 (fi) Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
PL290676A1 (en) Method of obtaining novel derivatives of 2-aminoalkyl-5-diaryl-alkyl-1.3-dioxane
DK0861250T3 (da) Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
NO20023041L (no) Fremgangsmåte for fremstilling av pyrazolopyridazinderivater
MY116281A (en) A combination of a selective 5-ht 1a antagonist and a selective h5-ht 1b antagonist or partial agonist.
DK0885004T3 (da) Anvendelse af 4-phenyl-3,6-dihydro-2H-pyridyl-derivater som NMDA-receptor-undertypeblokkere
DK0906295T3 (da) Dibenzo-oxazepin- og -dioxepinderivater og deres anvendelse som anti-tumormidler
WO2002062801A1 (fr) Derives de triazoloquinazoline et de pyrazolotriazolopyrimidine, compositions pharmaceutiques, agents presentant une affinite pour le recepteur de l'adenosine a3, agents de reduction de la tension oculaire, preparations pour prevenir et traiter un glaucome et methode pour reduire la tension oculaire
SE9800835D0 (sv) New Compounds
SE9901901D0 (sv) Compounds
AR017500A1 (es) Derivados de naftilpiperacin-ftalacinonas
DK0514267T3 (da) Hidtil ukendte amidderivater af 1-aminooctahydropyrido(2,1-c)(1,4)oxazin, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application